Nucleosides and emerging viruses: A new story.

(Re)emerging RNA viruses Antiviral therapy Broad-spectrum antiviral agents Nucleoside analogues RNA-dependent RNA polymerase (RdRp)

Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
07 2022
Historique:
received: 07 10 2021
revised: 13 01 2022
accepted: 16 02 2022
pubmed: 22 2 2022
medline: 22 6 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

With several US Food and Drug Administration (FDA)-approved drugs and high barriers to resistance, nucleoside and nucleotide analogs remain the cornerstone of antiviral therapies for not only herpesviruses, but also HIV and hepatitis viruses (B and C); however, with the exception of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for which vaccines have been developed at unprecedented speed, there are no vaccines or small antivirals yet available for (re)emerging viruses, which are primarily RNA viruses. Thus, herein, we present an overview of ribonucleoside analogs recently developed and acting as inhibitors of the viral RNA-dependent RNA polymerase (RdRp). They are new lead structures that will be exploited for the discovery of new antiviral nucleosides.

Identifiants

pubmed: 35189369
pii: S1359-6446(22)00070-8
doi: 10.1016/j.drudis.2022.02.013
pmc: PMC8856764
pii:
doi:

Substances chimiques

Antiviral Agents 0
Nucleosides 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1945-1953

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

ChemMedChem. 2009 Nov;4(11):1779-91
pubmed: 19760699
Phys Chem Chem Phys. 2021 Mar 14;23(10):5852-5863
pubmed: 33688867
Clin Microbiol Rev. 2003 Oct;16(4):569-96
pubmed: 14557287
J Med Chem. 2017 Mar 9;60(5):1648-1661
pubmed: 28124907
PLoS One. 2015 Sep 23;10(9):e0139001
pubmed: 26397100
Nat Med. 2021 Mar;27(3):401-410
pubmed: 33723456
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33558299
J Med Chem. 2012 Mar 22;55(6):2481-531
pubmed: 22185586
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618775243
pubmed: 29792071
Int J Infect Dis. 2021 Feb;103:62-71
pubmed: 33212256
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12411-2
pubmed: 11035785
Chem Soc Rev. 2021 Apr 26;50(8):5126-5164
pubmed: 33644787
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891600
Antimicrob Agents Chemother. 2010 Aug;54(8):3187-96
pubmed: 20516278
Nat Struct Mol Biol. 2021 Sep;28(9):706-708
pubmed: 34518697
Antimicrob Agents Chemother. 2004 Oct;48(10):3944-53
pubmed: 15388457
Nat Struct Mol Biol. 2021 Sep;28(9):740-746
pubmed: 34381216
Antiviral Res. 2017 Aug;144:147-152
pubmed: 28629988
Antiviral Res. 2010 Apr;86(1):101-20
pubmed: 20417378
J Virol. 2019 Nov 26;93(24):
pubmed: 31578288
Antiviral Res. 2011 Nov;92(2):277-91
pubmed: 21878354
J Med Chem. 2018 Mar 22;61(6):2211-2226
pubmed: 28792763
Engineering (Beijing). 2020 Oct;6(10):1192-1198
pubmed: 32346491
Virology. 2019 Feb;528:64-72
pubmed: 30576861
mBio. 2018 Nov 27;9(6):
pubmed: 30482837
Molecules. 2020 Dec 03;25(23):
pubmed: 33287144
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618758524
pubmed: 29534607
J Mol Biol. 2002 Nov 15;324(1):47-62
pubmed: 12421558
J Med Chem. 1995 Mar 31;38(7):1174-88
pubmed: 7707320
Antiviral Res. 2018 Jun;154:66-86
pubmed: 29649496
J Virol. 2016 Jul 27;90(16):7415-7428
pubmed: 27279608
Exp Mol Med. 2021 May;53(5):711-712
pubmed: 33953321
Sci Transl Med. 2020 Apr 29;12(541):
pubmed: 32253226
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620976786
pubmed: 33297724
PLoS One. 2020 Jan 8;15(1):e0227104
pubmed: 31914458
ACS Chem Biol. 2016 Nov 18;11(11):3165-3171
pubmed: 27668519
PLoS Pathog. 2010 Jul 22;6(7):e1001005
pubmed: 20661479
Antiviral Res. 2021 Nov;195:105180
pubmed: 34551346
J Med Chem. 1972 Nov;15(11):1150-4
pubmed: 4347550
Blood Transfus. 2009 Jul;7(3):167-71
pubmed: 19657478
Viruses. 2015 Dec 01;7(12):6233-40
pubmed: 26633464
Science. 1972 Aug 25;177(4050):705-6
pubmed: 4340949
ACS Infect Dis. 2018 Feb 9;4(2):107-117
pubmed: 29151351
Nat Rev Drug Discov. 2005 Nov;4(11):928-40
pubmed: 16264436
Cell Mol Life Sci. 2014 Nov;71(22):4403-20
pubmed: 25080879
Acta Biochim Pol. 1996;43(1):196-208
pubmed: 8790724
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Nat Microbiol. 2019 Jan;4(1):10-19
pubmed: 30546099
FEBS Lett. 1994 Aug 29;351(1):11-4
pubmed: 8076677
J Med Chem. 2004 Oct 7;47(21):5284-97
pubmed: 15456273
Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1431-4
pubmed: 18066799
Antiviral Res. 2018 Aug;156:38-45
pubmed: 29864447
Life Sci. 2020 Jul 15;253:117592
pubmed: 32222463
Nature. 2016 Mar 17;531(7594):381-5
pubmed: 26934220
J Virol. 2013 Apr;87(7):3741-51
pubmed: 23325689
J Med Chem. 2010 Oct 14;53(19):7202-18
pubmed: 20845908
Cell Mol Life Sci. 2015 Mar;72(6):1115-25
pubmed: 25416679
Microbiol Spectr. 2013 Oct;1(1):
pubmed: 26184815
ILAR J. 2017 Dec 15;58(3):343-358
pubmed: 28985316
Curr Opin Virol. 2014 Dec;9:143-7
pubmed: 25462446
Front Immunol. 2019 Mar 28;10:549
pubmed: 30984169
Clin Infect Dis. 2021 Aug 2;73(3):531-534
pubmed: 32770240
World J Clin Cases. 2021 Jul 6;9(19):5135-5178
pubmed: 34307564
J Mol Med (Berl). 2002 Feb;80(2):86-95
pubmed: 11907645
Rev Med Virol. 2006 Jan-Feb;16(1):37-48
pubmed: 16287208
Antiviral Res. 2019 Feb;162:5-21
pubmed: 30529089
Br J Pharmacol. 2006 Jan;147(1):1-11
pubmed: 16284630
Beilstein J Org Chem. 2018 Apr 5;14:772-785
pubmed: 29719574
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137799
Viruses. 2018 Feb 10;10(2):
pubmed: 29439438
ACS Infect Dis. 2021 Feb 12;7(2):471-478
pubmed: 33395259
Antiviral Res. 2019 Nov;171:104597
pubmed: 31494195
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Nov;37(9):602-608
pubmed: 29907366
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20
pubmed: 202961
Int J Environ Res Public Health. 2020 Dec 15;17(24):
pubmed: 33333995
Chem Rev. 2014 Sep 24;114(18):9154-218
pubmed: 25144792
PLoS Biol. 2018 Aug 13;16(8):e3000003
pubmed: 30102691
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463
pubmed: 28769016
Curr Opin Infect Dis. 2015 Dec;28(6):596-602
pubmed: 26524332
Drugs. 2009;69(2):151-66
pubmed: 19228073
Acta Virol. 2017;61(1):48-55
pubmed: 28105854
Int J Antimicrob Agents. 2020 Jun;55(6):105948
pubmed: 32201353
Antiviral Res. 2016 Sep;133:119-29
pubmed: 27476046
Biochim Biophys Acta. 1959 Mar;32(1):295-6
pubmed: 13628760
Subcell Biochem. 2018;88:39-71
pubmed: 29900492
ACS Med Chem Lett. 2021 Mar 29;12(4):510-517
pubmed: 33854700

Auteurs

Vincent Roy (V)

ICOA, University of Orléans, CNRS UMR 7311, Rue de Chartres, 45067 Orléans, France.

Luigi A Agrofoglio (LA)

ICOA, University of Orléans, CNRS UMR 7311, Rue de Chartres, 45067 Orléans, France. Electronic address: luigi.agrofoglio@univ-orleans.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH